Home > Insider Trading > Filing (0001494650-22-000106)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1494650	Optinose Inc.	OPTN	Pharmaceutical Preparations (2834)	421771610

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1502700	Iii F Michael Marino	C/O Optinose, Inc. 1020 Stony Hill Road, Suite 300 Yardley PA 19067	Chief Legal Officer & Corp Sec	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-09-15	3,816	$0.00	187,262	No	4	A	Direct
Common Stock	Disposition	2022-09-16	1,583	$3.55	185,679	No	4	S	Direct
Common Stock	Disposition	2022-09-20	1,151	$3.56	184,528	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the grant of performance-based restricted stock units (Performance RSUs) on March 6, 2020. Fifty percent (50%) of the Performance RSUs vested on June 15, 2022, upon achievement of certain milestones in connection with the Company's development programs. The balance vests in eight equal quarterly installments, subject to continued service with the Issuer. Each Performance RSU represents the right to receive one share of common stock of OptiNose, Inc.
Includes 14,160 shares acquired under the Optinose, Inc. 2017 Employee Stock Purchase Plan on June 30, 2022 at a price of $1.50
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.